الأعمال العلمية
التدريب والبحث والمقالات والمساهمات العلمية
تستند القائمة إلى السيرة المهنية وسجلات الناشرين. تُعرض العناوين والاستشهادات بلغة المصدر.
أعمال مختارة
تصفّح جميع الأعمالPrimary Stromal sarcoma of the breast with nodal recurrence
Iranian Journal of PathologyComparison of 5FU-based chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer
Iranian Journal of Pathologyتصفّح جميع الأعمال
الكتبلا توجد عناصر تطابق عوامل التصفية.
The Investigation of Clinical Profile and Outcomes of Metastatic Colorectal Cancer Patients with RAS or BRAF Mutations in Iran
Matoofi A, Yaghobi Joybari A, Azadeh P, Kalantari Khandani M. International Journal of Cancer Management. 2025. doi:10.5812/ijcm-161595.
اقرأ المقال على موقع الناشرPrimary Stromal sarcoma of the breast with nodal recurrence
Yaghobi, Ali, Azadeh, Payam, Moghadam, Shiva, Shafaghi, Behrouz, Primary Stromal sarcoma of the breast with nodal recurrence, Iranian Journal of Pathology, Iranian Journal of Pathology (2010)5 (1), 43- 46.
Comparison of 5FU-based chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer
Yaghobi, Ali, Azadeh, Payam, Sheibani, Kh.M, Foudazi, M., Shafaghi, B., Davaei, M., Comparison of 5FU-based chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer, Iranian Journal of Pathology (2011) 6(3):110-116.
Paclitaxel-Induced Fingerprints Loss
Azadeh, Payam, Yaghobi, Ali, Amini, Afshin, Farasatinasab, Maryam Paclitaxel-Induced Fingerprints Loss, Annals of Pharmacotherapy, 2014, vol48 (9) 1249-1250.
Orbital Metastasis From Breast Cancer Without Significant Changes In CT Scan And MRI
Azadeh, Payam, Hassanzadeh Rad, Babak, Yaghobi, Ali, Orbital Metastasis From Breast Cancer Without Significant Changes In CT Scan And MRI, Iranian Journal Of Radiology, 2016, 13(2):e20004.
Von Hippel-Lindau Disease with Multi-Organ Involvement: A Case Report and 8-Year Clinical Course with Follow-Up
Yaghobi, Ali, Azadeh, Payam, Von Hippel-Lindau Disease with Multi-Organ Involvement: A Case Report and 8-Year Clinical Course with Follow-Up, Am J Case Rep, 2017, 18: 1220-1224.
Oxaliplatin-Induced Renal Tubular Vacuolization
Yaghobi, Ali, Sarbaz, Samaneh, Azadeh, Payam, Mirafsharieh, S.Abbas, Rahbari, Ali, Farasatinasab, Maryam, Mokhtari, Majid, Oxaliplatin-Induced Renal Tubular Vacuolization, Annals Of Pharmacotherapy, 2014,vol48(6) 796- 800.
Solitary Psoas Muscle Metastasis Of Gastroesophageal Junction, Adenocarcinoma
Azadeh, Payam, Yaghobi, Ali, Sarbaz, Samaneh, Ghiasi, Hosein Ali, Farasatinasab, Maryam, Solitary Psoas Muscle Metastasis Of Gastroesophageal Junction, Adenocarcinoma, Iranian Journal of Pathology, 2015
Cutaneous Verrucous Carcinoma superimposed on Chronically Inflamed Ileostomy Site Skin, a case report
Yaghobi, Ali, Azadeh, Payam, Nemati Honar, Behzad, Cutaneous Verrucous Carcinoma superimposed on Chronically Inflamed Ileostomy Site Skin, a case report,, Iranian Journal of Pathology, 2018, 13(2): 209-217.
Jaw Pain as a First Presentation in the Diagnosis of Breast Cancer
Azadeh, Payam, Rakhashani, Nasser, Yaghobi, Ali, Gorji Bayani, Pegah, Sarbaz, Samaneh, Farasatinasab, Maryam, Jaw Pain as a First Presentation in the Diagnosis of Breast Cancer, Iranian Journal of Pathology, 2016; 11(5): 439-442.
Fingerprint changes among cancer patients treated with paclitaxel
Azadeh, Payam, Khavidaki, Simin Dashti, Yaghobi, Ali, Sarbaz, Samaneh, Jafari, Atefeh, Yaseri, Mehdi, Amini, Afshin, Farasatinasab, Maryam, Fingerprint changes among cancer patients treated with paclitaxel, J Cancer Res Clin Oncol, published online 2016
Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer
Yaghobi, Ali, Azadeh, Payam, Babaei, Siamak, Hosseini Kamal, Farnaz, Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer pathology and oncology research, 2019, 25(4): 1599-1605
Capecitabine induced fingerprint changes
Yaghobi, Ali, Azadeh, Payam. Ghiasi, Hosein A., Amouzegar, Atefeh, Yaseri, Mehdi, Amini, Afshin, Farasatinasab3, Maryam, Mokhtari, Majid, Capecitabine induced fingerprint changes, journal of clinical pharmacy and therapeutics, 2019, 44(5):780-787.
Pseudo-CT Generation for External Radiotherapy Planning from Magnetic Resonance Imaging Data on Brain Regions
Yousefi Moteghaed, Niloofar, Yaghobi, Ali, Mostaar, Ahmad, Pseudo-CT Generation for External Radiotherapy Planning from Magnetic Resonance Imaging Data on Brain Regions,, Iranian Journal of Radiology, 2019, 16(3):e82804
Medical Image Fusion Using BEMD and an Efficient Fusion Schema
Mostaar, Ahmad, Yaghobi, Ali, Medical Image Fusion Using BEMD and an Efficient Fusion Schema, Journal of Biomedical Physics and Engineering, 2018
Comparison of breast absorbed dose in conventional and digital mamography machines in the actual condition used in Tabriz
Rezapour, Jafar, Paydar, Reza, Mostaar, Ahmad, Yaghobi, Ali, Comparison of breast absorbed dose in conventional and digital mamography machines in the actual condition used in Tabriz, Research in Medicine 2018, 42(1): 40-45
Turning Interdisciplinary Brain Tumor Science into Survival; Report from the Neuro-Oncology Scientific Club Opening Session, NOSC 2012 -19 January- Tehran
Haddad, Peiman, Zali, Alireza, Tabatabaeefar, Morteza, Nikoofar, Alireza, Hadizadeh Kharazi, Homayoun, Ghadyani, Mojtaba Fadavi,, Pedram, Vossough, Parvaneh, Mousavizadeh, Mirahmad, Mehdizadeh, Mahshid, Motlagh, Ali, Amoozegar Hashemi, Farnaz, Ameri, Ahmad, Yaghobi, Ali, Turning Interdisciplinary Brain Tumor Science into Survival; Report from the Neuro-Oncology Scientific Club Opening Session, NOSC 2012 -19 January- Tehran, IR Iran Report and Opinion, 2012;4:(2)
Herceptin treatment in gastro esophageal adenocarcinoma
Yaghobi, Ali, Herceptin treatment in gastro esophageal adenocarcinoma, Iranian Journal of Pathology, November 30, 2009 (consecutive 40)
CDX2, CK7, CK20, CDX2 Useful markers for distinguishing colorectal metastatic carcinoma with ovarian involvement from primary ovarian adenocarcinoma
Yaghobi, Ali, CDX2, CK7, CK20, CDX2 Useful markers for distinguishing colorectal metastatic carcinoma with ovarian involvement from primary ovarian adenocarcinoma, Iranian Journal of Pathology, Azar and D89 (consecutive 41)
Pathological evaluation of TME rectal cancer sample
Yaghobi, Ali, Pathological evaluation of TME rectal cancer sample, Iranian Journal of Pathology, April and May 1990 (consecutive 43)
Treatment and prophylaxis of VTE in cancer patients:
Yaghobi, Ali, Treatment and prophylaxis of VTE in cancer patients: Commentary agreed by the main guidelines in the eighth issue of the Scientific-News Magazine of the Iranian Cancer Society
Prevention, diagnosis and treatment of VTE in cancer patients
Yaghobi, Ali, Prevention, diagnosis and treatment of VTE in cancer patients in the book How to deal with oncology emergencies of the Iranian Cancer Society
New biological and diagnostic factors predicting the results of treatment in early stage breast cancer
Yaghobi, Ali, New biological and diagnostic factors predicting the results of treatment in early stage breast cancer, Iranian Journal of Pathology, June and July 1990 (consecutive 44)
Targeted value-added therapy in oncology
Yaghobi, Ali, Targeted value-added therapy in oncology, Iranian Journal of Pathology, August and September 1990 (consecutive 45)
IHC's position in the diagnosis of metastatic carcinoma of unknown origin (CUP)
Yaghobi, Ali, IHC's position in the diagnosis of metastatic carcinoma of unknown origin (CUP), Iranian Journal of Pathology, Mehr and Aban 90 (consecutive 46)
Gastrointestinal Stromal Tumors (GIST)
Yaghobi, Ali, Gastrointestinal Stromal Tumors (GIST), Iranian Journal of Pathological Association, Bahman and Esfand 90 (consecutive 48)
Diagnosis of pancreatic tumors by (EUS)
Yaghobi, Ali, Diagnosis of pancreatic tumors by (EUS), Iranian Journal of Pathology, April and May 1991 (consecutive 49)
Molecular mechanism of resistance to cytotoxic resistance
Yaghobi, Ali, Molecular mechanism of resistance to cytotoxic resistance, Iranian Journal of Pathology, Esfand 92 (consecutive 56)
Hepatocellular carcinoma
Yaghobi, Ali, Hepatocellular carcinoma, Journal of the Iranian Society of Pathology, Esfand 92 91 (consecutive 59.60)
Treatment and prophylaxis of venous thromboembolism in cancer patients
Yaghobi, Ali, Treatment and prophylaxis of venous thromboembolism in cancer patients, Iranian Journal of Pathology, July 1993 (consecutive, 6162)
Agreed guidelines for the treatment of neuroendocrine tumors with hepatic metastasis
Yaghobi, Ali, Agreed guidelines for the treatment of neuroendocrine tumors with hepatic metastasis, Iranian Journal of Pathology, August and September 1993 (consecutive 63)
Non-functional pancreatic neuroendocrine tumors with good differentiation
Yaghobi, Ali, Non-functional pancreatic neuroendocrine tumors with good differentiation, Iranian Journal of Pathology Association, Azar and D 93 (consecutive 65)
Should Dose Taxoter be an optional option in patients with metastatic prostate cancer
Yaghobi, Ali, Should Dose Taxoter be an optional option in patients with metastatic prostate cancer, Iranian Journal of Pathology, Bahman and Esfand 94 (consecutive 72)
A Review of Glioblastoma Multiform Treatment
Yaghobi, Ali, A Review of Glioblastoma Multiform Treatment, Journal of Iranian Pathology Association, June and July 2016 (consecutive 74)
Instructions and management of patients with metastatic colorectal cancer
Yaghobi, Ali, Instructions and management of patients with metastatic colorectal cancer, Iranian Journal of Pathology, Bahman and Esfand 2016 (consecutive 78)
treatment & diagnostic guideline in epithelial ovarian cancer
Yaghobi, Ali, treatment & diagnostic guideline in epithelial ovarian cancer, Iranian Journal of Pathology, khordad & Tir 2016, (consecutive 80)
change of treatment protocol in metastatic melanoma
Yaghobi, Ali, change of treatment protocol in metastatic melanoma, Iranian Journal of Pathology, farvardin & ordibehesht 2018, (consecutive 85)
metastatic breast cancer HR positive,HER2 negative
Yaghobi, Ali, metastatic breast cancer HR positive,HER2 negative, Iranian Journal of Pathology, Bahman & Esfand 2019, (consecutive 85)
Immuno oncology fourth potent pillar in treatment of oncology
Yaghobi, Ali, Immuno oncology fourth potent pillar in treatment of oncology, Iranian Journal of Pathology, khordad & Tir 2019, (consecutive 85)
treatment strategy in advanced breast cancer
Yaghobi, Ali, treatment strategy in advanced breast cancer, Iranian Journal of Pathology, Mehr & Aban 2019, (consecutive 85)
integrity biomarkers & target therapy in management of metastatic colorectal cancer
Yaghobi, Ali, integrity biomarkers & target therapy in management of metastatic colorectal cancer, Iranian Journal of Pathology, Bahman & Esfand 2020, (consecutive 85)
what is ideal treatment in cancer of gastroesophageal junction
Yaghobi, Ali, what is ideal treatment in cancer of gastroesophageal junction,farvardin & ordibehesht 2020 (consecutive 97)
do you think what is ideal treatment for Gastroesophageal junction carcinoma ?
Yaghobi, Ali, do you think what is ideal treatment for Gastroesophageal junction carcinoma ? (consecutive 98)
investigate the prevalence and causes of occupational depression (Burnout) in caregivers of cancer patients of the Iranian Cancer Society
Collaborator in the National Research Project to investigate the prevalence and causes of occupational depression (Burnout) in caregivers of cancer patients of the Iranian Cancer Society
study the causes and problems of patients with cancer and its relationship with socio-economic factors in Iran Cancer Society of Iran
Collaborator in a Research Project to study the causes and problems of patients with cancer and its relationship with socio-economic factors in Iran Cancer Society of Iran
the relationship between mRNA genes of TS & ERCC1 genes with clinical pathological features and tumor location in gastrointestinal cancers of the Iranian Cancer Society
Collaborator in a Research Project on the relationship between mRNA genes of TS & ERCC1 genes with clinical pathological features and tumor location in gastrointestinal cancers of the Iranian Cancer Society
Tinagrast clinical trial Research Project (Ariatinagen) compared to Neupogen (Amgen) for the prevention of fever and neutropenia caused by chemotherapy in Cancer Patients
Collaborator in Tinagrast clinical trial Research Project (Ariatinagen) compared to Neupogen (Amgen) for the prevention of fever and neutropenia caused by chemotherapy in Cancer Patients
study the clinical and pathological features and common treatments of gastric and breast cancer in Iran, Iranian Cancer Society
Collaborator in a Research Project to study the clinical and pathological features and common treatments of gastric and breast cancer in Iran, Iranian Cancer Society
investigate the response to treatment and the ability of resuscitation with chemotherapy in comparison with preoperative chemoradiation with a diet containing two taxol in cancer patients of the Iranian Cancer Society
Collaborator in a Research Project to investigate the response to treatment and the ability of resuscitation with chemotherapy in comparison with preoperative chemoradiation with a diet containing two taxol in cancer patients of the Iranian Cancer Society
Pharmacokinetics Assessment Of Paclinab® Formulation And Compared to Abraxane® Formulation In Patients With Solid Tumors
Executor of Research Project of Pharmacokinetics Assessment Of Paclinab® Formulation And Compared to Abraxane® Formulation In Patients With Solid Tumors
PDLASTA Formulation study Post-marketing
Executor of Research Project PDLASTA Formulation study Post-marketing
The value of DW-MRI in predicting pathologic complete response (pCR) after neoadjuvant chemoradiation in patient with rectal cancer who referred to Imam Hossein hospital during July 2018 to July 2019
Executor of Research Project of The value of DW-MRI in predicting pathologic complete response (pCR) after neoadjuvant chemoradiation in patient with rectal cancer who referred to Imam Hossein hospital during July 2018 to July 2019
Evaluation of treatment outcomes of induction chemotherapy and then Neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer
Executor of Research Project of Evaluation of treatment outcomes of induction chemotherapy and then Neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer
the predictive value of cardiac biochemical markers including high sensitive cardiac troponin-I (HSCT-I), NT-Pro-BNP and two dimensional echocardiography in early detection of acute and sub acute cardiac toxicity in patients who are treated by anthracycline drug.
Collaborator in a Research Project of the predictive value of cardiac biochemical markers including high sensitive cardiac troponin-I (HSCT-I), NT-Pro-BNP and two dimensional echocardiography in early detection of acute and sub acute cardiac toxicity in patients who are treated by anthracycline drug.
A comparison survey on the combination Aprepitant - dexamethasone - Ondansetron, vs. Placebo-dexamethasone - Ondansetron, for prevention of Moderate Emetogenic Chemotherapy Regimens- Induced Nausea and Vomiting
Collaborator in a Research Project of A comparison survey on the combination Aprepitant - dexamethasone - Ondansetron, vs. Placebo-dexamethasone - Ondansetron, for prevention of Moderate Emetogenic Chemotherapy Regimens- Induced Nausea and Vomiting
Evaluation of Estrogen, Progesterone & HER2 receptor in Iranian population of Breast Cancer
Collaborator in a Research Project of Evaluation of Estrogen, Progesterone & HER2 receptor in Iranian population of Breast Cancer
Breast Cancer Guideline
Breast Cancer Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Colon Cancer Guideline
Colon Cancer Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Bevacizumab Drug Guideline
Bevacizumab Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Imatinib Drug Guideline
Imatinib Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Pemetrexed Drug Guideline
Pemetrexed Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Sorafenib Drug Guideline
Sorafenib Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Liposomal Doxorubicin Drug Guideline
Liposomal Doxorubicin Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Temozolomide Drug Guideline
Temozolomide Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Bortezomib Drug Guideline
Bortezomib Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Rituximab Drug Guideline
Rituximab Drug Guideline, Member of the Oncology Guideline Committee in Ministry of Health
Management of Oncologic patients in Corona Pandemic
Management of Oncologic patients in Corona Pandemic, Member of the Oncology Guideline Committee in Ministry of Health
Prostate Cancer Guideline
Prostate Cancer Guideline, Member of the Guideline Committee of Uro oncology in SBMU Urology research center
Testicular Cancer Guideline
Testicular Cancer Guideline, Member of the Guideline Committee of Uro oncology in SBMU Urology research center
Kidney Cancer Guideline
Kidney Cancer Guideline, Member of the Guideline Committee of Uro oncology in SBMU Urology research center
Bladder Cancer Guideline
Bladder Cancer Guideline, Member of the Guideline Committee of Uro oncology in SBMU Urology research center
Primary Gastric Melanoma
Primary Gastric Melanoma, in 3th Annual Congress of Iranian Cancer Association, Iran-Tehran
Primary high grade MALT Lymphoma of breast presented lymphoepithelial ulcer
Primary high grade MALT Lymphoma of breast presented lymphoepithelial ulcer in 3th Annual Congress of Iranian Cancer Association, Iran-Tehran
Colorectal Cancer: Microsatellite Instability (MSI) Testing
Colorectal Cancer: Microsatellite Instability (MSI) Testing in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
Meta-analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer: Secondary End Points
Meta-analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer: Secondary End Points in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in esophageal carcinoma: a meta-analysis
Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in esophageal carcinoma: a meta-analysis. in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
A case of sigmoid endometriosis difficult to differentiate from colon cancer
A case of sigmoid endometriosis difficult to differentiate from colon cancer in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
Doctors Conclude Temsirolimus Is Effective New Treatment for Advanced Renal Cell Carcinoma
Doctors Conclude Temsirolimus Is Effective New Treatment for Advanced Renal Cell Carcinoma in 4th Annual Congress of Iranian Cancer Association, Iran- Tehran oct.22-24 2008
What is Oncotype DX ®
What is Oncotype DX ® in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
Gene Testing Predicts Response to Erbitux
Gene Testing Predicts Response to Erbitux in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value?
Serum Tumor Markers in Breast Cancer: Are They of Clinical Value? in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
Afinitor Earns FDA Approval for Advanced Kidney Cancer
Afinitor Earns FDA Approval for Advanced Kidney Cancer in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009
What's New in Chemotherapy Research?
What's New in Chemotherapy Research? in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009
Metastatic Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009
Second-Line Treatment of Glioblastoma
Second-Line Treatment of Glioblastoma in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009
Glivec (imatinib) now approved in the UK for post surgery treatment of patients with KIT(CD117)-positive GIST, who are at significant risk of the cancer returning after surgery
Glivec (imatinib) now approved in the UK for post surgery treatment of patients with KIT(CD117)-positive GIST, who are at significant risk of the cancer returning after surgery in 3th Annual Congress of clinical oncology, Iran- Tehran Feb.3-4 2010
Trastuzumab in HER2-positive advanced esophagogastric adenocarcinoma
Trastuzumab in HER2-positive advanced esophagogastric adenocarcinoma in 3th Annual Congress of clinical oncology, Iran-Tehran Feb.3-4 2010
Avastin delays progression of advanced ovarian cancer
Avastin delays progression of advanced ovarian cancer in 6th Annual Congress of Iranian Cancer Association, Iran-Tehran Nov. 17-19 2010
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic masses
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic masses in 6th Annual Congress of Iranian Cancer Association, Iran-Tehran Nov. 17-19 2010
SATURN trial
SATURN trial in 6th Annual Congress of Iranian Cancer Association, Iran- Tehran Nov. 17-19 2010
New treatment options in the management of glioblastoma multiform :a focus of bevacizumab
New treatment options in the management of glioblastoma multiform :a focus of bevacizumab in Annual Congress of clinical oncology, Iran-Tehran 2011
CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma
CK7, CK20, CDX2 and MUC2 immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma in Annual Congress of clinical oncology, Iran-Tehran 2011
Tarceva outperforms chemotherapy for initial treatment of lung cancer with an EGFR mutation
Tarceva outperforms chemotherapy for initial treatment of lung cancer with an EGFR mutation in 7th Annual Congress of Iranian Cancer Association, Iran-Tehran Oct. 19 – 21, 2011, Iran-Tehran
Three years of adjuvant Imatinib may be the new standard of care for high risk patients with GIST
Three years of adjuvant Imatinib may be the new standard of care for high risk patients with GIST in 7th Annual Congress of Iranian Cancer Association, Iran-Tehran Oct. 19 – 21, 2011, Iran-Tehran
Advisory committee recommends Everolimus for approval to treat advanced NET of pancreatic origin
Advisory committee recommends Everolimus for approval to treat advanced NET of pancreatic origin in 7th Annual Congress of Iranian Cancer Association, Iran-Tehran Oct. 19 – 21, 2011, Iran-Tehran
FOLFIRINOX versus Gemcitabine for metastatic pancreatic cancer
FOLFIRINOX versus Gemcitabine for metastatic pancreatic cancer in 7th Annual Congress of Iranian Cancer Association, Iran-Tehran Oct. 19 – 21, 2011, Iran-Tehran
CAR T cell immunotherapy for human cancer
CAR T cell immunotherapy for human cancer in 1st National congress on inflammation,Immunology and inflammatory disorders, 26 February 2019, Tehran
Cancer Treatment with Immune Checkpoint Inhibitors
Cancer Treatment with Immune Checkpoint Inhibitors in 1st National congress on inflammation,Immunology and inflammatory disorders, 26 February 2019, Tehran
Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials
Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials in 4th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.22-24 2008
Can Antibodies Help Cure Cancer?
Can Antibodies Help Cure Cancer? in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009
Comparison of 5FU-base chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer
Comparison of 5FU-base chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer in 5th Annual Congress of Iranian Cancer Association, Iran-Tehran oct.20-22 2009
Chemotherapy book
Yaghobi, Ali, Azadeh, Payam, Chemotherapy book, Clinical Guide For Patients & Families Volume 1,, Ali, Arjmand Publications, 2013
Chemotherapy book
Yaghobi, Ali, Azadeh, Payam, Chemotherapy book, Clinical Guide For Patients & Families Volume 1, Arjmand Publications, 2015, Second Edition
Chemotherapy book
Yaghobi, Ali, Azadeh, Payam Chemotherapy book, Clinical Guide For Patients & Families Volume 1,, Ali, Arjmand Publications, 2016, Third Edition
Breast Cancer Book
Yaghobi, Ali, Azadeh, Payam Breast Cancer Book, Clinical Guide For Patients & Families Volume 2, Arjmand Publications, 2013
Radiotherapy book
Yaghobi, Ali, Azadeh, Payam Radiotherapy book, Clinical Guide For Patients & Families Volume 3, Arjmand Publications, 2013
Radiotherapy book
Yaghobi, Ali, Azadeh, Payam Radiotherapy book, Clinical Guide For Patients & Families Volume 3, Arjmand Publications, 2015, Second Edition
Prostate Cancer Book
Yaghobi, Ali, Azadeh, Payam, Prostate Cancer Book, Clinical Guide For Patients & Families Volume 4,,, Arjmand Publications, 2013
Colorectal Cancer Book
Yaghobi, Ali, Azadeh, Payam, Colorectal Cancer Book, Clinical Guide For Patients & Families Volume 5, Colon Cancer, Ali Yaghobi Joybari,Payam Azadeh, Arjmand Publications, 2013
Cancer Pharmacotherapy book, the first volume, Chemotherapy Agents
Yaghobi, Ali, Azadeh, Payam, Cancer Pharmacotherapy book, the first volume, Chemotherapy Agents, Clinical Guide For Patients & Families Volume 6,, Ali Yaghobi Joybari, Maryam Farasati nasab, Payam Azadeh, Arjmand Publications, 2013
Cancer Pharmacotherapy book, Second Volume, Targeted Therapy for Cancer
Yaghobi, Ali, Azadeh, Payam, Farasati nasab, Maryam, Cancer Pharmacotherapy book, Second Volume, Targeted Therapy for Cancer, Clinical Guide For Patients & Families Volume 7, Payam Azadeh, Arjmand Publications, 2013
Cancer Pharmacotherapy book, third Volume, Hormone Therapy for Cancer
Yaghobi, Ali, Azadeh, Payam, Farasati nasab, Maryam Cancer Pharmacotherapy book, third Volume, Hormone Therapy for Cancer, Clinical Guide For Patients & Families Volume 8, Arjmand Publications, 2013
Pancreatic Cancer Book
Yaghobi, Ali, Azadeh, Payam, Pancreatic Cancer Book,Clinical Guide For Patients & Families Volume 9, Arjmand Publications, 2014
Esophageal Cancer Book
Yaghobi, Ali, Azadeh, Payam Esophageal Cancer Book,Clinical Guide For Patients & Families Volume 10, Arjmand Publications, 2014
Coping with Cancer book
Yaghobi, Ali, Azadeh, Payam Coping with Cancer book,Clinical Guide For Patients & Families Volume 11, Arjmand Publications, 2014
Marital Relationships in Cancer Patients
Yaghobi, Ali, Azadeh, Payam, Farasati nasab, Maryam, Marital Relationships in Cancer Patients Clinical Guide For Patients & Families Volume 12, Arjmand Publications, 2014
Gastric Cancer Book
Yaghobi, Ali, Azadeh, Payam Gastric Cancer Book, Clinical Guide For Patients & Families Volume 13, Arjmand Publications, 2015
The Clinical Application of Blood Book
Yaghobi, Ali, Azadeh, Payam The Clinical Application of Blood Book, Clinical Guide For Patients & Families Volume 14, Arjmand Publications, 2015
Nutrition & Cancer Book
Yaghobi, Ali, Tizdast, Neda, Azadeh, Payam, Nutrition & Cancer Book, Clinical Guide For Patients & Families Volume 15, Arjmand Publications, 2014
Nutrition & Cancer Book
Yaghobi, Ali, Tizdast, Neda, Azadeh, Payam, Nutrition & Cancer Book, Clinical Guide For Patients & Families Volume 15, Arjmand Publications, Second Edition, 2017
Pain & Cancer Book
Yaghobi, Ali, Azadeh, Payam, Nemati Honar, Behzad, Pain & Cancer Book,Clinical Guide For Patients & Families Volume 16, Arjmand Publications, 2014
Principle Of Chemotherapy In Special Clinical Situation Book
Taghizadeh, Ali, Yaghobi, Ali…[and etal], Principle Of Chemotherapy In Special Clinical Situation Book,, Arjmand Publications, 2014
Thromboembolism & Cancer Book
Yaghobi, Ali…[and etal], Thromboembolism & Cancer Book,, Arjmand Publications, 2014
Admission to the Faculty of Medicine
Admission to the Faculty of Medicine
Received a doctorate in General Medicine
Received a doctorate in General Medicine
Entry to the specialty course
Entry to the specialty course
Obtaining a specialized certificate in the field of Radiotherapy-Oncology
Obtaining a specialized certificate in the field of Radiotherapy-Oncology
Obtaining a specialized board in the field of Radiotherapy - Oncology
Obtaining a specialized board in the field of Radiotherapy - Oncology
Member of the faculty of the Department of Radiotherapy-Oncology, Imam Hossein Hospital
Member of the faculty of the Department of Radiotherapy-Oncology, Imam Hossein Hospital
Bone Densitometry in Tehran population
Bone Densitometry in Tehran population
Comparison of 5FU-based chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer
Comparison of 5FU-based chemoradiation with and without Eloxatin on Pathologic Complete Response in Neoadjuvant Chemoradiation of Rectal cancer